Inventor · disambiguated record
Yi He
Also filed as: HE YI · He yi-tian
12 granted patents·8 pending applications·6 citations·filing 1998–2023
83Inventor score
Files withTASLY PHARMACEUTICAL GROUP CO11NORDIC BIOSCIENCE AS4DEV CT BIOTECHNOLOGY1EISAI R&D MAN CO LTD1IND RES LTD1
Top patents by PatentIndex Score
20 records- 0179US12090138B2Pharmaceutical composition containing silybin and VETASLY PHARMACEUTICAL GROUP CO·Filed 2022·Granted Sep 17, 2024·0 cites·8 claims
- 0265US10307395B2Pharmaceutical composition containing silybin and L-carnitineTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Jun 4, 2019·0 cites·20 claims
- 0365US10307396B2Pharmaceutical composition containing silybin, VE and L-carnitineTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Jun 4, 2019·0 cites·20 claims
- 0461US11531028B2Collagen type X alpha-1 assayNORDIC BIOSCIENCE AS·Filed 2020·Granted Dec 20, 2022·0 cites·8 claims
- 0561US10507197B2Pharmaceutical composition containing silibininTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Dec 17, 2019·0 cites·20 claims
- 0660US11318112B2Pharmaceutical composition containing silybin and veTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted May 3, 2022·0 cites·18 claims
- 0760US10376491B2Pharmaceutical composition containing silibinin and pueraria root extractTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Aug 13, 2019·0 cites·20 claims
- 0859US2023390353A1Pharmaceutical composition for treating myocardial ischemia and preparation method thereforTASLY PHARMACEUTICAL GROUP CO·Filed 2022·Application pending·0 cites
- 0956US2024197780A1Chimeric antigen receptors, nucleic acids encoding the same, and uses thereof in treating cancersDEV CT BIOTECHNOLOGY·Filed 2023·Application pending·0 cites
- 1054US12366582B2Collagen type X alpha-1 assayNORDIC BIOSCIENCE AS·Filed 2022·Granted Jul 22, 2025·0 cites·13 claims
- 1148US12343433B2Microencapsulation method for improving stability of anthocyanin, product therefrom and use thereofUNIV WUHAN POLYTECHNIC·Filed 2021·Granted Jul 1, 2025·0 cites·8 claims
- 1247US2016123993A1Collagen Type X Alpha-1 AssayNORDIC BIOSCIENCE AS·Filed 2014·Application pending·0 cites
- 1345US2021038668A1Traditional chinese medicine composition for preventing and/or treating ischemic reperfusion injuryTASLY PHARMACEUTICAL GROUP CO·Filed 2019·Application pending·0 cites
- 1442US11491173B2Pharmaceutical composition and application thereofTASLY PHARMACEUTICAL GROUP CO·Filed 2019·Granted Nov 8, 2022·0 cites·19 claims
- 1542US2022395539A1Traditional chinese medicine composition for treating psoriasis, preparation method therefor and use thereofTASLY PHARMACEUTICAL GROUP CO·Filed 2020·Application pending·0 cites
- 1638US2020173991A1Collagen Type X Alpha-1 AssayNORDIC BIOSCIENCE AS·Filed 2018·Application pending·0 cites
- 1737US10376490B2Pharmaceutical composition containing silybinTASLY PHARMACEUTICAL GROUP CO·Filed 2016·Granted Aug 13, 2019·0 cites·17 claims
- 1836US6379709B1Angiogenesis inhibitors and activators from shark cartilageIND RES LTD·Filed 1998·Granted Apr 30, 2002·6 cites·12 claims
- 1935US2014163095A1Use of eribulin in the treatment of breast cancerEISAI R&D MAN CO LTD·Filed 2013·Application pending·0 cites
- 2035US2021115437A1In vitro synthesis method for sgrna and kit thereofSHANGHAI SINOBIO BIOTECH CO LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yi He files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →